大便潛血試驗市場規模、佔有率及成長分析（按檢測類型、最終用戶和地區）- 產業預測，2025 年至 2032 年

2023 年全球大便潛血試驗市場規模價值 1,925.7 億美元，預計將從 2024 年的 2068.2 億美元成長到 2032 年的 3,661.2 億美元，預測期內（2025-2032 年）的複合年成長率為 7.4%。

全球大便潛血試驗市場對於檢測糞便樣本中的隱藏血液至關重要，並且是早期結腸癌診斷和監測各種胃腸道疾病的關鍵方法。大腸直腸癌發生率的上升、政府對篩檢的支持、醫療保健基礎設施的改善以及創新檢測技術的採用是推動市場成長的一些因素。然而，認知的差距和高成本對擴張構成了挑戰。機會包括直接面對消費者的檢測選項的興起，以及家庭免疫檢測設備的線上可用性。市場按產品類型分類，例如癒創木脂FOB測試和免疫學FOB測試，並為各種最終用戶提供服務，包括各個地區的醫院和檢測機構，主要在北美和歐洲。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析

大便潛血試驗市場規模（依檢測類型及複合年成長率） （2025-2032）

• 市場概況
• 癒創木脂 FOB糞便檢驗
• 免疫FOB凝集試驗
• 橫向流動免疫螢光檢測
• 免疫 FOB ELISA 檢測

大便潛血試驗市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 大腸直腸癌
• 消化道出血
• 貧血
• 其他

大便潛血試驗市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 診斷中心
• 其他

大便潛血試驗市場規模（依地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Quidel Corporation（United States）
• Wondfo（China）
• Siemens Healthineers（Germany）
• Eiken Chemical Co., Ltd.（Japan）
• Biohit Oyj（Finland）
• Becton, Dickinson and Company（BD）（United States）
• Trinity Biotech（Ireland）
• Meridian Bioscience（United States）
• Beckman Coulter（United States）
• Inova Diagnostics（United States）
• Bio-Rad Laboratories（United States）
• Abbott Laboratories（United States）
• Roche Diagnostics（Switzerland）
• Sysmex Corporation（Japan）
• US Diagnostics（United States）
• Sekisui Diagnostics（United States）
• FUJIFILM Wako Pure Chemical Corporation（Japan）
• Helena Laboratories（United States）
• Exact Sciences Corp.（United States）

結論和建議

Global Fecal Occult Testing Market size was valued at USD 192.57 billion in 2023 and is poised to grow from USD 206.82 billion in 2024 to USD 366.12 billion by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

The global fecal occult testing market is crucial for detecting hidden blood in stool samples, serving as a key method for early colon cancer diagnosis and monitoring various gastrointestinal conditions. Market growth is fueled by increasing rates of colorectal cancer, supportive government initiatives for screening, improvements in medical infrastructure, and the adoption of innovative testing techniques. However, awareness gaps and high costs pose challenges to expansion. Opportunities arise from the rise of direct-to-consumer testing options and the availability of at-home immunological test devices online. The market is categorized by product types, including guaiac FOB tests and immuno-FOB tests, and serves diverse end users such as hospitals and laboratories across regions, notably North America and Europe.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fecal Occult Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fecal Occult Testing Market Segments Analysis

Global Fecal Occult Testing Market is segmented by Test Type, Application, End-use and Region. Based on Test Type, the market is segmented into Guaiac FOB stool test, Immuno-FOB agglutination test, Lateral flow immuno-FOB test and Immuno-FOB ELISA test. Based on Application, the market is segmented into Colorectal Cancer, Gastrointestinal Bleeding, Anemia and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fecal Occult Testing Market

The Global Fecal Occult Testing market is significantly influenced by rising public awareness campaigns and healthcare initiatives that emphasize the necessity of colorectal cancer screening. These efforts have heightened understanding among both the general public and healthcare professionals regarding the critical role of regular screening in early detection. Additionally, government-supported screening programs and established guidelines advocating for routine fecal occult blood testing in specific age demographics are further propelling the demand for these essential tests. As awareness continues to grow, more individuals are likely to participate in screening, thereby driving market expansion and fostering early diagnosis and treatment of colorectal cancer.

Restraints in the Global Fecal Occult Testing Market

The global fecal occult testing market faces significant restraints due to the potential for false positive and false negative results, which can lead to diagnostic inaccuracies that affect patient care. False positives may result in unnecessary follow-up tests or procedures, causing patient anxiety and increased healthcare costs. On the other hand, false negatives may lead to overlooked diagnoses, delaying vital treatments. It is essential to address these limitations regarding the sensitivity and specificity of fecal occult blood tests to ensure the preservation of trust in their diagnostic capacity, ultimately impacting the market's growth and acceptance among healthcare practitioners and patients alike.

Market Trends of the Global Fecal Occult Testing Market

The global fecal occult testing market is witnessing a significant trend towards point-of-care testing, driven by the demand for rapid and convenient diagnostic solutions. These tests, optimized for primary care settings and community health clinics, particularly enhance accessibility in remote and underserved areas lacking laboratory facilities. The focus is on developing user-friendly, cost-effective point-of-care tests that enable broader screening opportunities and improve early detection rates of gastrointestinal diseases. This trend is expected to expand the market further, as healthcare providers increasingly embrace technologies that facilitate timely patient care and enhance health outcomes in resource-constrained environments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Fecal Occult Testing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Guaiac FOB stool test
• Immuno-FOB agglutination test
• Lateral flow immuno-FOB test
• Immuno-FOB ELISA test

Global Fecal Occult Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Colorectal Cancer
• Gastrointestinal Bleeding
• Anemia
• Others

Global Fecal Occult Testing Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic centers
• Others

Global Fecal Occult Testing Market Size & CAGR (2025-2032)

• North America (Test Type, Application, End-use)
  • US
  • Canada
• Europe (Test Type, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Quidel Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wondfo (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eiken Chemical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biohit Oyj (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• US Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Wako Pure Chemical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations